Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma.
Sun M, Cao Y, Okada R, Reyes-González JM, Stack HG, Qin H, Li N, Seibert C, Kelly MC, Ruppin E, Ho M, Thiele CJ, Nguyen R.
Sun M, et al. Among authors: li n.
J Immunother Cancer. 2023 Jan;11(1):e005881. doi: 10.1136/jitc-2022-005881.
J Immunother Cancer. 2023.
PMID: 36631162
Free PMC article.